Home   >  
∨

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

Hormone Pathay

Chemical Structure Cat. No. Product Name CAS No.
Luxdegalutamide Chemical Structure
 BCP49650 Luxdegalutamide 2750830-09-0
Luxdegalutamide is an orally active and potent proteolysis targeting chimera (PROTAC) protein degrader. Luxdegalutamide degrades wild-type androgen receptor (AR) but also relevant AR LBD mutants, including the most prevalent AR L702H, H875Y, and T878A mutations.
Protirelin Acetate Chemical Structure
 BCP40636 Protirelin Acetate 120876-23-5
Protirelin Acetate is a thyrotropin-releasing hormone, stimulating the release of thyrotropin and prolactin from the anterior pituitary.
GPR81 agonist 1 Chemical Structure
 BCP36389 GPR81 agonist 1 1620992-67-7
GPR81 agonist 1 is a potent and highly selective GPR81 agonist, with EC50s of 58 nM and 50 nM for human and mouse GPR81, respectively.
Masofaniten Chemical Structure
 BCP49523 Masofaniten 2416716-62-4
Masofaniten is an antiandrogen and an antineoplastic.
LPCN-1144 Chemical Structure
 BCP49389 LPCN-1144 LPCN-1144
LPCN 1144 is an oral prodrug of bioidentical testosterone that is absorbed through intestinal lymphatics and intended for the treatment of hypogonadism in males.
AC-0176 Chemical Structure
 BCP49348 AC-0176 AC-0176
AC176 is an investigational medicinal product that is a potent orally bioavailable Androgen Receptor (AR) degrader.
OP-1250 Chemical Structure
 BCP49307 OP-1250 OP-1250
OP-1250 is a novel oral compound developed to completely antagonize the estrogen receptor (ER) and block the ER-mediated cancer cell growth and proliferation signal.
Onapristone Chemical Structure
 BCP49272 Onapristone 96346-61-1
Onapristone is a progesterone receptor antagonist potentially for the treatment of breast cancer, advanced prostate cancer, and inducer of vaginal bleeding.
TERN-501 Chemical Structure
 BCP49228 TERN-501 TERN-501
TERN 501 is an orally administered, small molecule therapeutic, being developed as a thyroid hormone receptor beta (THR-β) agonist, for the treatment of.
Naloxone HCl Chemical Structure
 BCP06880 Naloxone HCl 357-08-4
Naloxone hydrochloride is a hydrochloride resulting from the formal reaction of equimolar amounts of naloxone and hydrogen chloride. A specific opioid antagonist, it is used to reverse the effects of opioids, both following their use of opioids during surgery and in cases of known or suspected opioid overdose. It has a role as an antidote to opioid poisoning, a mu-opioid receptor antagonist and a central nervous system depressant. It contains a naloxone(1+).
123下一页末页共 357 条记录 1 / 36 页 
0086-13720134139